Pantoprazol Sun (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun belongs to the proton pump inhibitor class and is indicated for disorders involving excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Erosive gastritis and duodenal ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with the condition.

Pantoprazol Sun may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Severe hypersensitivity reactions: rash, angioedema, anaphylaxis. - Osteoporosis‑related fractures: increased risk with long‑term use. - Low magnesium (hypomagnesemia): may cause muscle cramps or arrhythmia.

Before initiating therapy, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review hepatic status: use with caution in moderate liver disease. - Evaluate concomitant medications: potential for drug‑drug interactions. - Monitor long‑term users: watch for bone density loss and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs. Awareness of interaction severity helps guide monitoring.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Antiplatelet agents (clopidogrel): possible reduction in antiplatelet effect. - Warfarin: potential alteration of INR values. - Digoxin: increased serum levels. - Methotrexate: reduced renal clearance at high doses.